According to Assertio Therapeutics
's latest financial reports the company has $0.13 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.13 B | -38.86% |
2022-12-31 | $0.22 B | 120.4% |
2021-12-31 | $0.10 B | 84.48% |
2020-12-31 | $55.51 M | -4.22% |
2019-12-31 | $57.95 M | -73.7% |
2018-12-31 | $0.22 B | 29.99% |
2017-12-31 | $0.16 B | -32.41% |
2016-12-31 | $0.25 B | -20.4% |
2015-12-31 | $0.31 B | -13.55% |
2014-12-31 | $0.36 B | 165.21% |
2013-12-31 | $0.13 B | 63.72% |
2012-12-31 | $83.93 M | -20.75% |
2011-12-31 | $0.10 B | 358.4% |
2010-12-31 | $23.1 M | 46.93% |
2009-12-31 | $15.72 M | -52.57% |
2008-12-31 | $33.15 M | -27.17% |
2007-12-31 | $45.52 M | -266.81% |
2006-12-31 | $-27.29 M | -503.62% |
2005-12-31 | $6.76 M | -19.54% |
2004-12-31 | $8.4 M | -75.7% |
2003-12-31 | $34.57 M | -639.08% |
2002-12-31 | $-6.42 M | 334.19% |
2001-12-31 | $-1.48 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $1.38 B | 906.66% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $10.67 M | -92.27% | ๐บ๐ธ USA |